跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 88 条关于
“Nanexa”
全部
88
临床试验
30
药物
13
机构
13
资讯
32
9个月前
Moderna Partners with Nanexa on PharmaShell Drug Delivery Technology in $500M Deal
去年
Nanexa's NEX-22 Shows Promise as Once-Monthly GLP-1 Therapy in Phase I Trial
2年前
Signatera MRD Test Demonstrates Clinical Utility in Colorectal and Breast Cancer Studies
去年
Crinetics Pharmaceuticals Presents Promising Neuroendocrine Tumor Therapies at NANETS 2024
去年
Natera's Signatera Shows Promise in Colorectal Cancer MRD Detection and Early Detection
6个月前
Natera Launches Zenith Genomics Platform with Methylation Analysis for Rare Disease Diagnosis
去年
Anixa Biosciences Bolsters Clinical Development with Suyasha Gupta Appointment
9个月前
Natera Acquires Foresight Diagnostics for $275 Million to Advance Molecular Residual Disease Detection
去年
Ernexa Therapeutics Expands Operations with Texas Subsidiary to Advance Ovarian Cancer Cell Therapy
去年
NeoGenomics Wins Patent Dispute Against Natera, Clears Path for RaDaR ST Assay Commercialization
第 1 页,共 4 页
上一页
下一页